InspireMD (NSPR) Cash from Investing Activities (2010 - 2025)

InspireMD's (NSPR) quarterly Cash from Investing Activities came in at -$45.1 million in Q4 2025, down 647.62% year-on-year from $8.2 million in Q4 2024, and down 697.74% quarter-over-quarter from $7.6 million in Q3 2025.

InspireMD (NSPR) Cash from Investing Activities (2010 - 2025) Analysis & Trends

InspireMD's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$45.1 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 647.62% year-over-year to -$45.1 million in Q4 2025; TTM through Dec 2025 was -$30.6 million, a 341.75% decrease from a year earlier, with the FY2025 full-year figure at -$30.6 million, down 341.75% from the prior year.
  • Cash from Investing Activities eased to -$45.1 million in Q4 2025 per NSPR's latest filing, from $7.6 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $8.2 million in Q4 2024 and bottomed at -$45.1 million in Q4 2025.
  • The 5-year median for Cash from Investing Activities is $1.9 million (2021), against an average of -$2.4 million.
  • Across the five-year window, Cash from Investing Activities slumped 49255.1% in 2021 and surged 22994.44% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at $1.8 million in 2021, then jumped by 111.08% to $3.9 million in 2022, then slumped by 100.93% to -$36000.0 in 2023, then jumped by 22994.44% to $8.2 million in 2024, then plunged by 647.62% to -$45.1 million in 2025.
  • Per Business Quant, the three latest NSPR Cash from Investing Activities figures stand at -$45.1 million (Q4 2025), $7.6 million (Q3 2025), and $5.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.86 Bn 176.56 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.65 Bn 125.78 Bn 3.81 Bn -185.00 Mn
3 Medtronic 108.75 Bn 99.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 68.34 Bn 66.89 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.33 Bn 44.65 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 28.35 Bn 26.07 Bn 1.98 Bn -2.50 Bn
7 Dexcom 28.33 Bn 27.21 Bn 750.30 Mn -298.50 Mn
8 Smith & Nephew 26.90 Bn 26.32 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn -475.32 Mn
10 InspireMD 42.52 Mn -11.69 Mn 1.18 Mn -45.14 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -45.14 Mn
Dec 31, 2025 -45.14 Mn
Sep 30, 2025 7.55 Mn
Sep 30, 2025 7.55 Mn
Jun 30, 2025 5.32 Mn
Jun 30, 2025 5.32 Mn
Mar 31, 2025 1.70 Mn
Mar 31, 2025 1.70 Mn
Dec 31, 2024 8.24 Mn
Dec 31, 2024 8.24 Mn
Sep 30, 2024 -5.92 Mn
Sep 30, 2024 -5.92 Mn
Jun 30, 2024 5.51 Mn
Jun 30, 2024 5.51 Mn
Mar 31, 2024 4.82 Mn
Mar 31, 2024 4.82 Mn
Dec 31, 2023 -36,000.00
Dec 31, 2023 -36,000.00
Sep 30, 2023 6.39 Mn
Sep 30, 2023 6.39 Mn